All Stories

  1. Global health at crossroads: uniting together to overcome challenges, restore trust and advance priorities for a sustainable future
  2. Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study...
  3. Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
  4. Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950–2023: a demographic analysis for the Global Burden of Disease Study 2023
  5. GBD 2023 Cardiovascular Disease Collaborators
  6. Global, regional, and national prevalence of kidney failure with replacement therapy and associated aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
  7. Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023
  8. Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019
  9. Global, regional and national burden of dietary iron deficiency from 1990 to 2021: a Global Burden of Disease study
  10. Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
  11. Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
  12. Global, regional, and national burden of HIV/AIDS, 1990–2021, and forecasts to 2050, for 204 countries and territories: the Global Burden of Disease Study 2021
  13. Global, regional, and national progress towards the 2030 global nutrition targets and forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021
  14. Global, regional, and national stillbirths at 20 weeks' gestation or longer in 204 countries and territories, 1990–2021: findings from the Global Burden of Disease Study 2021
  15. Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  16. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  17. Global Health Trends 1950–2021: Impact of COVID-19 on Mortality and Population Growth
  18. Ten golden rules for optimal antibiotic use in hospital settings: the WARNING call to action
  19. Current rates of purchasing of antibiotics without a prescription across sub-saharan Africa; rationale and potential programmes to reduce inappropriate dispensing and resistance
  20. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021
  21. Validation of Kiswahili Version of WHOQOL-HIV BREF questionnaire among people living with HIV/AIDS in Tanzania- a cross sectional study
  22. Mapping age- and sex-specific HIV prevalence in adults in sub-Saharan Africa, 2000–2018
  23. Solid Fuel Use and Health in Developing Countries
  24. Coronavirus Disease 2019 (COVID-19) Pandemic across Africa: Current Status of Vaccinations and Implications for the Future
  25. Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  26. The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019
  27. The prevalence of depression and its associated factors among patients with diabetes mellitus attending a tertiary clinic in Gaborone, Botswana
  28. Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019
  29. Acquired Factor VII Deficiency Presenting with Bleeding Diathesis in a 52-Year-Old Black Man in Botswana
  30. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019
  31. Challenges and Innovations Brought about by the COVID-19 Pandemic Regarding Medical and Pharmacy Education Especially in Africa and Implications for the Future
  32. The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019
  33. Global, regional, and national sex-specific burden and control of the HIV epidemic
  34. Mapping Anemia in Women: Global Trends and Inequality
  35. Global, regional, and national mortality among young people aged 10–24 years, 1950–2019: a systematic analysis for the Global Burden of Disease Study 2019
  36. Measuring routine childhood vaccination coverage in 204 countries and territories
  37. The Current Situation Regarding Long-Acting Insulin Analogues Including Biosimilars Among African, Asian, European, and South American Countries; Findings and Implications for the Future
  38. Mapping inequalities in exclusive breastfeeding in low- and middle-income countries, 2000–2018
  39. Mapping subnational HIV mortality in six Latin American countries with incomplete vital registration systems
  40. Prevalence and Risk Factors for Hepatitis B and C Among End-stage Renal Disease Patients on Hemodialysis in Gaborone, Botswana
  41. Metabolic Control and Determinants Among HIV-Infected Type 2 Diabetes Mellitus Patients Attending a Tertiary Clinic in Botswana
  42. Mapping routine measles vaccination in low- and middle-income countries
  43. Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
  44. Alanine transaminase and hemoglobin appear to predict the occurrence of antituberculosis medication hepatotoxicity; findings and implications in Botswana
  45. Five insights from the Global Burden of Disease Study 2019
  46. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019
  47. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  48. Response to the Novel Corona Virus (COVID-19) Pandemic Across Africa: Successes, Challenges, and Implications for the Future
  49. Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  50. Ongoing and planned activities to improve the management of patients with Type 1 diabetes across Africa; implications for the future
  51. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
  52. Fixed dose drug combinations – are they pharmacoeconomically sound? Findings and implications especially for lower- and middle-income countries
  53. Turner syndrome in diverse populations
  54. Adjustments of medication dosages in patients with renal impairment in Botswana; findings and implications to improve patient care
  55. Dolutegravir induced sub-acute hepatic failure in HIV positive treatment naïve man in Botswana
  56. Antimicrobial utilization research and activities in Botswana, the past, present and the future
  57. Determinants of comprehensive knowledge of mother to child transmission (MTCT) of HIV and its prevention among Zimbabwean women: Analysis of 2015 Zimbabwe Demographic and Health Survey
  58. Determinants of glycemic control among diabetes mellitus patients in a tertiary clinic in Gaborone, Botswana: findings and implications
  59. Short stature and growth hormone deficiency: unexpected manifestations of McCune-Albright syndrome
  60. Chronic kidney disease among diabetes mellitus patients in Botswana
  61. Antidiabetic medication adherence and associated factors among patients in Botswana; implications for the future
  62. Health-related quality of life and associated factors among patients with diabetes mellitus in Botswana
  63. The prevalence of microalbuminuria and associated factors among patients with type 2 diabetes mellitus in Botswana
  64. Leydig cell tumor of the testis presenting with gynaecomastia due to hyperprolactinemia after orchiectomy
  65. Cavernous sinus thrombosis in a 14-year old boy
  66. Disseminated Burkitt’s Lymphoma with a Pancreatic Mass in a HIV Positive Woman Diagnosed by Axillary Lymph Node Biopsy
  67. The prevalence of chronic kidney disease and associated factors among patients admitted at princess marina hospital, Gaborone, Botswana
  68. Outcome of the second Medicines Utilisation Research in Africa Group meeting to promote sustainable and appropriate medicine use in Africa
  69. A rare case of turner syndrome mosaicism in an African black woman
  70. Metastatic cutaneous epithelioid hemangioendothelioma involving right atrium - a case report
  71. An audit of consent practices and perceptions of lumbar puncture, Botswana inpatient setting experience
  72. The triad of Iron deficiency anemia, hepatosplenomegaly and growth retardation with normal serum zinc levels in a 14-year-old boy
  73. Isolated tubercular hepatic abscess with diffuse pattern mimicking hepatocellular carcinoma in HIV positive patient: a case report
  74. Asthma prevalence, knowledge, and perceptions among secondary school pupils in rural and urban coastal districts in Tanzania
  75. Adherence to anti-diabetic drugs among patients with Type 2 diabetes mellitus at Muhimbili National Hospital, Dar es Salaam, Tanzania- A cross-sectional study
  76. Chronic multiple lung abscesses presenting as a Left lung apical mass: a ticking bomb?
  77. Pulmonary artery thrombosis in a patient with right-sided heart failure
  78. Non-communicable diseases in antiretroviral therapy recipients in Kagera Tanzania: a cross-sectional study